Organon to acquire Dermavant for $1.2bn, expanding its presence in immuno-dermatology

Organon, a global healthcare company focused on women’s health, has announced a definitive agreement to acquire Dermavant Sciences Ltd., a Roivant company specialising in immuno-dermatology, ... Read More